EDCTP at UNGA76 Science Summit
The Science Summit takes place online from 14-30 September 2021, around the 76th United Nations General Assembly (UNGA76) in New York. The objective of the virtual meeting will be to raise awareness of the role and contribution of science to the attainment of the United Nations Sustainable Development Goals (SDGs). It will demonstrate initiatives that provide models for global science mechanisms and activities in support of the SDGs, particularly in science infrastructure and capacity building.
Opening plenary | 14 September
EDCTP’s Executive Director, Dr Michael Makanga, will speak at the UNGA76 Science Summit Opening Plenary: ‘How Science is Support the Attainment of the SDGs and how UNGA77 can do more to advance global science collaboration?’ During his talk at 17:20 CEST, Dr Makanga will provide a short overview of EDCTP and our UNGA76 Science Summit session taking place on 22 September, as well as highlighting the challenges and opportunities in developing countries for conducting global health clinical research in support of the SDGs.
Date: 14 September 2021
Time: 15:00 – 20:00 CEST
EDCTP will organise a virtual meeting entitled “EDCTP: an EU-Africa partnership advancing global health research and cooperation”, which will take place on 22 September 2021. The event will be part of the second edition of the UNGA76 Science Summit around the 76th United Nations General Assembly (SSUNGA76) in September 2021.
EDCTP session | 22 September
Objectives of the session
This EDCTP session will aim to advance the broader discussion on how to ensure sustained support and advancement along the continuum of product development for infectious diseases, including scale-up, implementation and access in sub-Saharan Africa and globally, in the pursuit of achieving the health-related targets of the 2030 Agenda for Sustainable Development.
Date: 22 September 2021
Time: 15:00 – 17:00 CEST
More information
Registration is free
Speakers
The session speakers will include:
- Pedro Alonso, World Health Organization (WHO), Switzerland
- Ruxandra Draghia-Akli, Johnson & Johnson, USA
- Barbara Kerstiëns, European Commission, Belgium
- Peter Kilmarx, Fogarty International Center, National Institutes of Health, USA
- Nkando Luo, EDCTP General Assembly representative, Zambia
- Michael Makanga, EDCTP Executive Director, the Netherlands
- Melinda Moree, Bill & Melinda Gates Foundation, USA
- Margareth Ndomondo-Sigonda, AUDA-NEPAD, South Africa
- Seamus O’Brien, Global Antibiotic Research & Development Partnership (GARDP), Switzerland
- Catarina Resende de Oliveira, Agency for Clinical Research and Biomedical Innovation (AICIB), Portugal
- Magda Robalo Correia e Silva, Minister in the Office of the President – High Commissioner for COVID-19, Guinea-Bissau
- Leonardo Simão, EDCTP High Representative, Africa
- Anthony Solomon, World Health Organization (WHO), Switzerland
- Marcel Tanner, EDCTP High Representative, Europe
- Marleen Temmerman, Aga Khan University, Kenya
- Daan du Toit, Department of Science and Innovation, South Africa
A set of recommendations on clinical trial infrastructure and capacity building in Africa arising from a session hosted by the European Clinical Infrastructure Networks (ECRIN) and EDCTP on 17 June 2021 at the Africa-Europe Science and Innovation Summit will also be further discussed.
More information
For more details and updates please visit the EDCTP SSUNGA76 session website.